Bullish BLSH
37.58
(2.11)
(5.32%)
as of 25 Sep
- Market cap
- $6.0B
- P/E
- 0.0×
Follow BLSH
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+7 more quarters Free account |
P/S ratio |
0.02 | 0.02 | 0.02 | 0.03 | |
P/FCF ratio |
30.56 | 46.58 | 677.24 | 0.00 | |
P/Operating CF |
210.47 | 59.40 | 78.23 | (181.55) | |
P/B ratio |
1.44 | 2.00 | 1.47 | 2.13 | |
Price to Tangible BV |
1.50 | 2.07 | 1.51 | 2.18 | |
EV/Sales |
0.01 | 0.02 | 0.02 | 0.03 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 124.86 | |
EV/Operating CF |
22.09 | 37.79 | 133.80 | 1,346.74 | |
EV/FCF |
23.36 | 40.14 | 536.39 | (564.50) | |
Quick Ratio |
10.68 | 10.68 | 12.06 | 14.39 | |
Current Ratio |
23.52 | 26.42 | 29.28 | 38.78 | |
Net Debt/EBITDA |
2.97 | 1.20 | 1.75 | (21.67) | |
Debt/Assets |
16.10% | 14.67% | 14.18% | 12.37% | |
Debt/Equity |
0.20 | 0.18 | 0.17 | 0.14 | |
Asset Turnover |
60.15 | 72.33 | 69.95 | 106.68 | |
Operating CF/Net income |
(0.06) | (0.16) | (0.11) | (2.53) | |
Capex/Depreciation |
0.13 | 1.37 | (8.46) | (1.10) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.17% | 0.09% | 0.07% | 0.11% | |
Intangible Assets out of Total Assets |
0.03 | 0.03 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.02% | 0.01% | 0.01% | 0.01% | |
Graham Net Nets |
0.65 | 0.47 | 0.65 | 0.45 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(39.35%) | (18.16%) | (15.10%) | (0.91%) | |
Free Cash Flow Yield |
3.27% | 2.15% | 0.15% | (0.15%) | |
Revenue per Share |
215.25 | 343.18 | 504.23 | 313.00 | |
Operating CF per Share |
0.11 | 0.60 | 0.48 | (0.35) | |
Capex per Share |
0.00 | 0.02 | (0.06) | (0.01) | |
Free Cash Flow per Share |
0.11 | 0.62 | 0.42 | (0.37) | |
Cash per Share |
8.80 | 8.50 | 12.27 | 12.52 | |
Shareholders Equity per Share |
16.22 | 17.88 | 25.82 | 29.90 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
16.22 | 17.88 | 25.82 | 29.90 | |
Free Cash Flow |
17.16 | 93.97 | 53.80 | (48.62) | |
Working Capital |
2,816.78 | 3,057.60 | 3,674.15 | 4,373.62 | |
Capital Expenditures |
0.27 | 3.05 | (8.03) | (1.99) | |
Net Current Asset Value |
2,305.15 | 2,557.03 | 3,145.89 | 3,844.06 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 145.19 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(0.83%) | (1.12%) | (0.85%) | 0.04% | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 166.73 | |
| Other line items | |||||
Average Inventory |
185.50 | 167.65 | 390.03 | 771.77 | |
Average Assets |
3,168.11 | 2,994.49 | 3,501.96 | 2,311.69 | |
Average Common Equity |
2,505.67 | 2,333.53 | 2,849.49 | 2,630.17 |
Columns are period end dates